Skip to content

BESINS HEALTHCARE PHARMTECH

Active
Public limited companyfounded 2019active for 7 yearsRue Louis Plescia 9, 4102 Seraing, BelgiumKBO/BCE: BE 0736.939.187

From the official registers: KBO 6 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of BESINS HEALTHCARE PHARMTECH is 3.0% (moderate). The 2025 annual accounts show negative equity (-€9.5m) and a net result of -€6.3m. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 10% of 94 sector peers (NACE 21, financial year 2025). The company has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow ReportCompare
BESINS HEALTHCARE PHARMTECHActiveChecked score 49/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 30-10-2019 Normal situation
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21201
Establishment unit
2.295.691.179 4102 Seraing, since 30-10-2019
Financial year end
31 December
Peppol
Reachable since 15-09-2025
Company details

Board and ownership

Board
Shareholders
and 1 other shareholder
Holdings
Shares in 1 company LSP2
Board & ownership

Financial position

49 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
3.0%
Annual accounts 2025
Turnover
€7.6m
▲ 25.3%
Loss
€6.3m
▲ 18.4%
Equity
-€9.5m
▼ 238%
Total assets
€23.7m
▼ 12.7%
Staff
41.1 FTE
▲ 22.7%
Filed on 15-07-2026, 16 days before the deadlineat the National Bank
Financials
Score breakdownraises riskNegative equity -€9.5mLiquidity: current ratio 0.16, cash €121,901Loss of €6.3m, the second in a row (financial year 2025)lowers riskFounded in 2019Show the evidence

Checked score

Score 2025
49 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 17% of small companies in pharmaceuticals (NACE 21)
Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 0-15
equity -40.1% of total assets
Liquidity 13-42
short-term debt 70.0% · cash 0.5%
Profitability 0=
return on assets -26.6%
Bankruptcy probability within 12 months
3.0% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (44 companies, NACE 21, small)
Last 24 months 11-2024: 1.0% 12-2024: 1.0%● unchanged vs 11-2024 01-2025: 1.0%● unchanged vs 12-2024 02-2025: 1.0%● unchanged vs 01-2025lowest value 03-2025: 1.0%● unchanged vs 02-2025 04-2025: 1.0%● unchanged vs 03-2025 05-2025: 1.0%● unchanged vs 04-2025 06-2025: 1.1%▲ +0.1 percentage points vs 05-2025 07-2025: 1.1%● unchanged vs 06-2025 08-2025: 1.6%▲ +0.5 percentage points vs 07-2025 09-2025: 1.7%▲ +0.1 percentage points vs 08-2025 10-2025: 1.8%▲ +0.1 percentage points vs 09-2025 11-2025: 1.8%● unchanged vs 10-2025 12-2025: 1.8%● unchanged vs 11-2025 01-2026: 1.8%● unchanged vs 12-2025 02-2026: 2.2%▲ +0.4 percentage points vs 01-2026 03-2026: 2.3%▲ +0.1 percentage points vs 02-2026 04-2026: 2.3%● unchanged vs 03-2026 05-2026: 2.3%● unchanged vs 04-2026 06-2026: 2.4%▲ +0.1 percentage points vs 05-2026 07-2026: 2.3%▼ -0.1 percentage points vs 06-2026 08-2026: 3.0%▲ +0.7 percentage points vs 07-2026 09-2026: 3.0%● unchanged vs 08-2026highest value 10-2026: 3.0%● unchanged vs 09-2026highest value
No credit on open account
Liquidity is insufficient, with a current ratio of 0.16 (0.34 in 2024), below 1. Short-term debt is 70% and cash 0.5% of total assets. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, small). It does better than 3% of them on solvency, 2% on liquidity, 14% on profitability and 49% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Negative equity -€9.5m
NBB · annual accounts
raises risk · Liquidity: current ratio 0.16, cash €121,901
NBB · annual accounts
raises risk · Loss of €6.3m, the second in a row (financial year 2025)
NBB · annual accounts
lowers risk · Founded in 2019
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
202122232425
2020 to 2025 · latest year -€9.5m
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
16 days early
2024
3 days early
2023
15 days early
2022
33 days early
2021
23 days late
2020
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 2 days before the deadline. In the sector (NACE 21), the median for financial year 2024 was 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Risk: Negative equitydebts exceed assets in financial year 2025 -€9.5m View
  • Risk: 5 loss-making years in a rowloss in financial year 2025 -€6.3m View
  • Caution: Equity fell in 2025from -€2.8m to -€9.5m ▼ 238% View
  • Caution: Lower net result than 95% of companies in pharmaceuticalssector median €358,461 · 94 companies -€6.3m View
  • Caution: Board changedlatest change 23-07-2026 · 4 in office 3 joined · 8 left View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Companies linked to BESINS HEALTHCARE PHARMTECH

Comparable companies

These companies have the same main activity as BESINS HEALTHCARE PHARMTECH: manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201). They are comparable in size and age: total assets between €9.5m and €53m, founded between 2015 and 2021.

CompanyTotal assetsGross margin
BESINS HEALTHCARE PHARMTECH Seraing€23.7m€1.2m
Cellistic Mont-Saint-Guibert€41.6m-
invoX Belgium Diepenbeek€29.2m€2.2m
Ziphius Gent€9.5m€2.4m
EPICS THERAPEUTICS Charleroi€14.7m€4.2m
Full-Life Technology Europe Gembloux€53.0m€2.1m
CENTRALE AFDELING VOOR FRACTIONERING Brussel€19.7m-
Full comparison

Documents

Annual accounts at the NBB

All 6 annual accounts

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about BESINS HEALTHCARE PHARMTECH
What is the company number of BESINS HEALTHCARE PHARMTECH?
The company number of BESINS HEALTHCARE PHARMTECH is 0736.939.187. The VAT number is the same number with BE in front: BE 0736.939.187.
Where is BESINS HEALTHCARE PHARMTECH based?
The registered office is at Rue Louis Plescia 9, 4102 Seraing.Company details
What does BESINS HEALTHCARE PHARMTECH do?
According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
What is the legal form of BESINS HEALTHCARE PHARMTECH?
The legal form of BESINS HEALTHCARE PHARMTECH is Public limited company (NV).
When was BESINS HEALTHCARE PHARMTECH founded?
BESINS HEALTHCARE PHARMTECH was founded on 30-10-2019.
Is BESINS HEALTHCARE PHARMTECH still active?
Yes, BESINS HEALTHCARE PHARMTECH is an active enterprise in the KBO register.
How many employees does BESINS HEALTHCARE PHARMTECH have?
BESINS HEALTHCARE PHARMTECH had an average of 41.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of BESINS HEALTHCARE PHARMTECH?
The turnover of BESINS HEALTHCARE PHARMTECH was €7.6m in financial year 2025, according to the filed annual accounts.
Is BESINS HEALTHCARE PHARMTECH profitable?
In financial year 2025, BESINS HEALTHCARE PHARMTECH made a loss of €6.3m.
Where can I find the annual accounts of BESINS HEALTHCARE PHARMTECH?
BESINS HEALTHCARE PHARMTECH filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of BESINS HEALTHCARE PHARMTECH due?
BESINS HEALTHCARE PHARMTECH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure